Response to omalizumab using patient enrichment criteria from trials of novel biologics in asthma

BACKGROUND: Recent efficacy studies of asthma biologics have included highly enriched patient populations. Using a similar approach, we examined factors that predict response to omalizumab to facilitate selection of patients most likely to derive the greatest clinical benefit from therapy. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Casale, T. B., Chipps, B. E., Rosén, K., Trzaskoma, B., Haselkorn, T., Omachi, T. A., Greenberg, S., Hanania, N. A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2017
Materias:
ORIGINAL ARTICLES
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813202/
https://www.ncbi.nlm.nih.gov/pubmed/28859263
http://dx.doi.org/10.1111/all.13302

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813202/
https://www.ncbi.nlm.nih.gov/pubmed/28859263
http://dx.doi.org/10.1111/all.13302

Ejemplares similares